---
title: "VYNE.US (VYNE.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VYNE.US/news.md"
symbol: "VYNE.US"
name: "VYNE.US"
parent: "https://longbridge.com/en/quote/VYNE.US.md"
datetime: "2026-05-21T22:32:37.378Z"
locales:
  - [en](https://longbridge.com/en/quote/VYNE.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VYNE.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VYNE.US/news.md)
---

# VYNE.US (VYNE.US) — Related News

### [Vyne Therapeutics publishes Yarrow Bioscience investor presentation factsheet](https://longbridge.com/en/news/287273372.md)
*2026-05-21T21:05:48.000Z*
> Vyne Therapeutics has published the 'Yarrow Bioscience Investor Presentation' dated May 21, 2026. The presentation is av

### [14:06 ETSHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--VYNE, MASI, IBCP, and HCBN](https://longbridge.com/en/news/281409785.md)
*2026-04-01T18:07:17.000Z*
> Class Action Attorney Juan Monteverde is investigating mergers involving VYNE Therapeutics, Masimo Corporation, Independ

### [VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance](https://longbridge.com/en/news/278798602.md)
*2026-03-12T01:04:24.000Z*
> VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance

### [08:42 ETSYNEVIT® Addresses Hormonal Imbalance Ahead of National Endometriosis Awareness Month](https://longbridge.com/en/news/278111027.md)
*2026-03-06T13:42:26.000Z*
> SYNEVIT® addresses hormonal imbalance in women ahead of National Endometriosis Awareness Month. A McKinsey report highli

### [Vyome’s Livechain Acquires Humanyze to Expand AI HR Analytics](https://longbridge.com/en/news/276953703.md)
*2026-02-25T22:55:13.000Z*
> Vyome Holdings' subsidiary, Livechain, has acquired Humanyze for $5.77 million in an all-stock deal, issuing 211.2 milli

### [Vynleads (OTCQB: VYND) Launches Done With Diabetes™ App, Bringing AI-Powered Daily Lifestyle Support to Blood Sugar and Metabolic Health | VYND Stock News](https://longbridge.com/en/news/275653099.md)
*2026-02-11T12:13:00.000Z*
> Vynleads (OTCQB: VYND) has launched the Done With Diabetes™ app, a digital wellness platform aimed at helping adults man

### [Investigation into VYNE Therapeutics Inc. for possible breaches of fiduciary duty in transaction with Yarrow Bioscience.](https://longbridge.com/en/news/270231144.md)
*2025-12-19T00:41:59.000Z*
> In Milwaukee on December 18, 2025, The Ademi Firm announced an investigation into VYNE (Nasdaq: VYNE) regarding potentia

### [19:39 ET
			
			
				Shareholder Alert: The Ademi Firm investigates whether VYNE Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders](https://longbridge.com/en/news/270229505.md)
*2025-12-19T00:40:19.000Z*
> The Ademi Firm is investigating VYNE Therapeutics Inc. for potential breaches of fiduciary duty in its transaction with